Emanuela Balestra

Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Soria, A., Alteri, C., Scarlatti, G., Bertoli, A., Tolazzi, M., Balestra, E., et al. (2017). Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report. CLINICAL INFECTIOUS DISEASES, 64(6), 3-15. Dettagli
  2. Alteri, C., Surdo, M., Bellocchi, M.c., Saccomandi, P., Continenza, F., Armenia, D., et al. (2015). Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 59(8), 4870-4881. Dettagli
  3. Surdo, M., Alteri, C., Puertas, M.C., Saccomandi, P., Parrotta, L., Swenson, L., et al. (2015). Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029. CLINICAL MICROBIOLOGY AND INFECTION, 21(1), 103.e1-103.e6. Dettagli
  4. Surdo, M., Balestra, E., Saccomandi, P., Di Santo, F., Montano, M., Di Carlo, D., et al. (2013). Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. PLOS ONE, 8(7), e68076-e68076. Dettagli
  5. Balzarini, J., Andrei, G., Balestra, E., Huskens, D., Vanpouille, C., Introini, A., et al. (2013). A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity. PLOS PATHOGENS, 9(7), e1003456-e1003456. Dettagli
  6. Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2012). The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients. CLINICAL MICROBIOLOGY AND INFECTION, 18(8). Dettagli
  7. Andrei, G., Lisco, A., Vanpouille, C., Introini, A., Balestra, E., van den Oord, J., et al. (2011). Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. CELL HOST & MICROBE, 10(4), 379-389. Dettagli
  8. Svicher, V., Balestra, E., Cento, V., Sarmati, L., Dori, L., Vandenbroucke, I., et al. (2011). HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. ANTIVIRAL RESEARCH, 90(1), 42-53. Dettagli
  9. Fraternale, A., Paoletti, M., Casabianca, A., Orlandi, C., Millo, E., Balestra, E., et al. (2009). Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain. JOURNAL OF DRUG TARGETING, 17(4), 278-285. Dettagli
  10. Rossi, L., Franchetti, P., PierigeĢ, F., Cappellacci, L., Serafini, S., Balestra, E., et al. (2007). Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 59(4), 666-675. Dettagli
  11. Babakir-Mina, M., Balestra, E., Perno, C.F., & Aquaro, S. (2007). Influenza virus A (H5N1): A pandemic risk?. NEW MICROBIOLOGICA, 30(2), 65-77. Dettagli
  12. Franchetti, P., Cappellacci, L., Petrelli, R., Vita, P., Grifantini, M., Rossi, L., et al. (2007). Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, 26(8-9), 953-957. Dettagli
  13. Casoli, C., Pilotti, E., Perno, C.F., Balestra, E., Polverini, E., Cassone, A., et al. (2006). A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication. AIDS, 20(7), 975-980. Dettagli
  14. Rossi, L., Serafini, S., Antonelli, A., PierigeĢ, F., Carnevali, A., Battistelli, V., et al. (2005). Macrophage depletion induced by clodronate-loaded erythrocytes. JOURNAL OF DRUG TARGETING, 13(2), 99-111. Dettagli
  15. Perno, C.F., Balestra, E., Francesconi, M., Abdelahad, D., Calio, R., Balzarini, J., et al. (2004). Antiviral profile of HIV inhibitors in macrophages: Implications for therapy. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 4(9), 1009-1015. Dettagli
  16. Aquaro, S., Panti, S., Caroleo, M., Balestra, E., Cenci, A., Forbici, F., et al. (2000). Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes. JOURNAL OF LEUKOCYTE BIOLOGY, 68(3), 429-435. Dettagli
  17. Perno, C.F., Balestra, E., Aquaro, S., Panti, S., Cenci, A., Lazzarino, G., et al. (1996). Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. MOLECULAR PHARMACOLOGY, 50(2), 359-366. Dettagli
  18. Perno, C.F., Aquaro, S., Rosenwirth, B., Balestra, E., Peichl, P., Billich, A., et al. (1994). In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. JOURNAL OF LEUKOCYTE BIOLOGY, 56(3), 381-386. Dettagli
  19. Villani N., C.R., Perno, C.F., & Del Gobbo, V. (1994). 9-(2-Phosphonylmethoxyethyl)adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system. ANTIVIRAL RESEARCH, 25(2), 81-89. Dettagli
  20. Del Gobbo, V., Foli, A., Balzarini, J., De Clercq, E., Balestra, E., Villani, N., et al. (1991). Immunomodulatory activity of 9-(2-phosphonyl-methoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models. ANTIVIRAL RESEARCH, 16(1), 65-75. Dettagli
  21. Del Gobbo V., V.N. (1990). Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice. IMMUNOLOGY, 69(3), 454-459. Dettagli